<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>indole-3-acetic acid decreases acute graft-versus-host disease — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>indole-3-acetic acid</strong>
  <span class="pred">&mdash;decreases&rarr;</span>
  <strong>acute graft-versus-host disease</strong>
</div>
<div class="entity-id">HMDB:HMDB0000193 &nbsp;&middot;&nbsp; MESH:D006086</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 200.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1038/s41467-019-13498-3">10.1038/s41467-019-13498-3</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS204">MTBLS204</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 20 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>13</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Nicotinamide adenine dinucleotide biosynthesis — correlates_with → Immune cell function regulation</span><a href="../claim/55d57aa6eda39c69.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Non-tolerant HSCT recipients — increases → CD38+ activated T and B cells</span><a href="../claim/c4e34059e800a16d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">NT5E (CD73) — is_biomarker_for → Operational tolerance (HSCT)</span><a href="../claim/80d7889762390995.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">NT5E (CD73) — increases → Adenosine</span><a href="../claim/e612c214947a7dd2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CD73 (NT5E) — inhibits → CD38 enzymatic function</span><a href="../claim/93483e0d29fbf113.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Adenosine — is_metabolite_of → Nicotinamide adenine dinucleotide</span><a href="../claim/fb62afaa1564756e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CD38 — activates → T and B cell immune activation</span><a href="../claim/138a979e6f2e3f4e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — inhibits → T-cell cytotoxicity against tumor cells</span><a href="../claim/0ecfb0130aa47667.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — inhibits → Glycolysis</span><a href="../claim/4bd3fc78f81b2991.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — decreases → Mitochondrial gene expression in T cells</span><a href="../claim/73600648e9d2ea01.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — increases → SOCS1 expression</span><a href="../claim/c9e8da65fb5dd544.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — increases → T cell immunomodulatory and exhausted profile</span><a href="../claim/10ebe87584625708.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — decreases → Energy metabolism pathway activity</span><a href="../claim/67ed1ea39e7818d4.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:15px"></span><span>2</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Androgens — is_biomarker_for → Operational tolerance (HSCT)</span><a href="../claim/c8e9d1cc132d5c59.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Azithromycin — causes → Relapse after allogeneic hematopoietic stem cell transplantation</span><a href="../claim/e0e5e6f9bae5f2a3.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:31px"></span><span>4</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Operational tolerance (HSCT) — increases → Regulatory T cell subsets</span><a href="../claim/df637ea551249d45.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Operational tolerance (HSCT) — decreases → T cell activation</span><a href="../claim/76446f50d7759736.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Operational tolerance (HSCT) — decreases → T cell proliferation</span><a href="../claim/bccb7afd28117b5d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Operational tolerance (HSCT) — decreases → T cell migration</span><a href="../claim/4f05865a2eeb61bc.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:8px"></span><span>1</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Operational tolerance (HSCT) — distinguishes → Non-tolerant HSCT recipients</span><a href="../claim/883e3fa0f6f605a4.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>1a7213d2f92efaa0</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000193">HMDB:HMDB0000193</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D006086">MESH:D006086</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
